SEC Form 4 · accession 0000899243-19-006234
ARVINAS, INC. · ARVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian Taylor
Officer — Senior Vice President, Biology
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 6:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001655759
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Mar 1, 2019 | A | 10,742 | A | — | — | Common Stock | 10,742 | 10,742 | D |
| Stock Option (right to buy)F3 | $19.36 | Mar 1, 2019 | A | 65,427 | A | — | Feb 28, 2029 | Common Stock | 65,427 | 65,427 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- F2The restricted stock units vest in four equal annual installments beginning March 1, 2020.
- F3This option award was granted on March 1, 2019. 1/4 of the shares underlying the award shall vest on March 1, 2020, with the remainder of the shares vesting in equal monthly installments following March 1, 2020 through March 1, 2023.